Keyphrases
Indonesia
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
68%
Surabaya
44%
AIDS/HIV
35%
CRF01_AE
31%
Drug Resistance mutations
26%
Antiretroviral Therapy
23%
COVID-19
21%
HIV Patients
19%
Helicobacter Pylori (H. pylori)
15%
Infected Individual
13%
Genotypic Characterization
11%
Bali
11%
HIV Drug Resistance
9%
Transmitted Drug Resistance
9%
In Vitro Study
8%
Bali Indonesia
8%
Viral
8%
Drug-treated
8%
University Hospital
8%
Immunoglobulin Y
8%
Hydroxychloroquine
8%
Helicobacter Pylori Infection
8%
AIDS Patients
8%
Drug Resistance
8%
Antiviral Activity
7%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
7%
Peripheral Blood Mononuclear Cells
7%
Nave
7%
Virus
6%
Human Immunodeficiency Virus Infection
6%
Reverse Transcriptase
6%
Antiretroviral Naïve
6%
High Prevalence
6%
Molecular Epidemiology
6%
Hepatitis B Virus
6%
Human Immunodeficiency Virus Drug Resistance
6%
East Java
6%
P24 Antigen
5%
Major mutations
5%
Reverse Transcriptase Gene
5%
Env Gene
5%
Indonesian
5%
Drug-naïve Individuals
5%
Transmitted Drug Resistance mutations
5%
Jakarta
5%
Drug Combination
5%
Hospitalized Patients
5%
Buleleng
5%
Stakeholder Collaboration
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
58%
Drug Resistance
35%
Human Immunodeficiency Virus 1
27%
Prevalence
21%
Infection
16%
Helicobacter Pylori
14%
Diseases
12%
SARS Coronavirus
10%
Antivirus Agent
9%
Hydroxychloroquine
8%
Coronavirinae
7%
RNA Directed DNA Polymerase
7%
Antiviral Activity
7%
Proteinase
6%
Acquired Immune Deficiency Syndrome
6%
Human Immunodeficiency Virus Infection
6%
Human Herpesvirus 8
5%
Immunoglobulin Y
5%
Opportunistic Infection
5%
Lopinavir Plus Ritonavir
5%
Anti-Human Immunodeficiency Virus
5%
Combination Drug
5%
Integrase
5%
Azithromycin
5%
RNA Directed DNA Polymerase Inhibitor
5%
Antibiotics
5%
Medicine and Dentistry
Human Immunodeficiency Virus 1
24%
Human Immunodeficiency Virus
22%
Drug Resistance
17%
Prevalence
17%
COVID-19
15%
Antiretroviral Therapy
10%
Infection
10%
Helicobacter Pylori
8%
Resistance Mutation
7%
HIV Drug Resistance
6%
Human Herpesvirus 8
5%
HIV/AIDS
5%
Molecular Epidemiology
5%
Diseases
5%
Virus
5%
Human Immunodeficiency Virus Infection
5%